News | October 16, 2024
Strides Pharma's CDMO arm OneSource raises Rs. 801 crore in pre-listing round
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Akums Drugs will undertake this development and commercialization in India
Aims to achieve CDMO sales of US$ 400 million by 2028
The recent inspection covered both cGMP and PAI processes
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Subscribe To Our Newsletter & Stay Updated
